DuPont Tate & Lyle BioProducts discuss latest clinical trials for Zemea

By Simon Pitman

- Last updated on GMT

At the recent Suppliers Day event in New Jersey, Cosmetics Design caught up with Steve Hurff, vice president of marketing and sales at DuPont Tate & Lyle, to find out about the latest clinical trials for its Zemea propanediol glycol alternative and its newest applications.

At the recent Suppliers Day event in New Jersey, Cosmetics Design caught up with Steve Hurff, vice president of marketing and sales at DuPont Tate & Lyle, to find out about the latest clinical trials for its Zemea propanediol glycol alternative and its newest applications.

Related topics: Formulation & Science

Related news